Mouse memory impairment induced by repeated daily dosing of lipopolysaccharide from Escherichia coli 044 was investigated using a passive avoidance method. One dose of 25 mg/kg or 8 repeated daily doses of 2.5 mg/kg of the lipopolysaccharide impaired the memory of 6-week-old male ddY mice. The chemical structure of the lipopolysaccharide was polymannoses Gal β1-3 GalNAc-lipid A. Humoral polymannose-lipid reactivity was not found in lipopolysaccharide or in control mice receiving repeated daily doses of physiological saline. Humoral glycolipid with Gal β1-3 GalNAc reactivity was found in the mice repeatedly treated with the lipopolysaccharide but not in the control mice repeatedly treated with physiological saline. Intraperitoneal injection of the humoral glycolipid did not impair memory in the normal mice, but mice treated beforehand with the glycolipid showed memory impairment after a subsequent single injection of 2.5 mg/kg of the lipopolysaccharide. These findings suggest that the polymannose component of the lipopolysaccharide is closely associated with the memory impairment effect and that the humoral glycolipid is a subsidiary metabolite of the lipopolysaccharide.
Studies have shown that high doses of lipopolysaccharides (LPS) induce mouse memory impairment (3, 11) , and this has been compared to delirium caused by inflammation (2) . However, some brain dysfunctions without brain lesions are thought to be associated with humoral glycolipids passing through the blood-brain barrier (4, 6) ; LPS are themselves glycolipids. These findings suggest that LPS impair memory by themselves and/or through metabolites, which are sugar chain structures. In the present study, we examined the effects of repeated treatment with LPS and detected the effective metabolite in mice.
MATERIALS AND METHOD
Detection of mouse memory impairment. Mouse memory impairment was detected by the passive avoidance method using the Passive-through apparatus (Obara Ikasangyo, Osaka, Japan). The main component of the apparatus is a shuttle box consisting of a bright chamber and a dark chamber whose floor gives an electric shock (150 V, 1 mA, 50 Hz) to a mouse ( Fig. 1) . Mice originally prefer the dark chamber. Mice placed in the bright chamber enter the dark chamber within 30 s. Subsequently, they are given an electric shock in the dark chamber, after which they immediately return to the bright chamber. Mice memorize the electric shock and avoid entering the dark chamber in the next trial. When a mouse still enters the dark chamber within 30 s, it is considered to have impaired memory (5) . The Animal Committee at Akita University Graduate School of Medicine approved the protocols for animal experimentation de-and left for 10 min at room temperature (RT). After adding 5 mL chloroform, the solution was agitated for 30 s. Following the addition of 4 mL water, the solution was agitated for 30 s. The solution was then centrifuged at 150 × g for 5 min at RT and was separated into the upper methanol-water layer containing proteins and the lower chloroform layer containing lipids and glycolipids. The lower layer was evaporated, and the remaining glycolipids were resolved in water. The glycolipid solution was applied to an ion exchanger DE-52 (Whatman Co., Maidstone, UK) previously saturated with 10 mM NaHCO 3 , pH 8.3. The remaining lipids were washed out with buffer and eluted with 50, 100, 150, 200, 250, and 300 mM NaCl. These elutions were further refined to 3-10 kDa using an ultrafiltration membrane (Centricon, Amicon Co., Tokyo) and diluted in 2 mL PS.
Association between humoral glycolipids and the effect of LPS. Another group of 30 mice were used for this experiment. They were given electric shocks as in the first two experiments. Three hundred microliters of each NaCl fraction separated from the sera of memory-impaired mice were injected intraperitoneally into 5 mice. Twenty minutes after injection, memory impairment was detected. Five minutes after the first detection, 2.5 mg/kg LPS was injected intraperitoneally into the 5 mice. Twenty minutes after the LPS injection, memory impairment was detected again. Another 15 mice were given electric shocks. These mice (each group: total 5 mice) were injected with 100, 300, or 500 μg/kg of glycolipid of the fraction eluted with 250 mM NaCl from the sera of memory-impaired mice. Twenty min after injection, memory impairment was detected. Five min after the first detection, 2.5 mg/kg LPS was injected into each mouse, and memory impairment was detected 20 min and 24 h after the LPS injection.
Detection of sugar chain structures of glycolipid.
For detecting the sugar chain structures of glycolipid, we performed 50% ethanol-lectin-ELISA (3). In brief, 50 μL of 1 mg/mL LPS (positive control), 50 μL of the fraction eluted with 250 mM NaCl from the sera of memory-impaired mice, 50 μL of the fraction eluted with 250 mM NaCl from the sera of control mice, or 50 μL of PS (negative control) was mixed with 50 μL ethanol, and each was poured into the wells of a 96-well plastic plate (Sumitomo Bakelite Co., Osaka, Japan). Two hours later, the well was washed three times with washing solution (WS; PS containing 0.005% Tween 20; Seikagaku Co., scribed in this paper, and all investigators adhered strictly to the University's Guidelines for Animal Experimentation.
Effects of single dosing of LPS.
Six-week-old male ddY mice (SLC Japan, Osaka, Japan) weighing 25-26 g were used for all experiments. In the first experiment, 20 mice were individually given electric shock in the dark chamber and their memory for the shock was confirmed 24 h later. After confirmation, 15, 20, or 25 mg/kg LPS from Escherichia coli 044 (kindly provided by Dr. Ken-ichi Amano at Bioscience Education and Research Center of Akita University) was dissolved in physiological saline (PS). As a control, 200 μL PS was injected intraperitoneally into 5 mice. Memory impairment was detected 20 min and 24 h after injection.
Effects of repeated dosing of LPS.
A second group of 18 mice were used for this experiment. They were each given electric shocks in the dark chamber, and their memory for the shock was confirmed 24 h later. Nine of them were injected daily for 8 days with 2.5 mg/kg LPS, and the other 9 were similarly treated with PS (control). From day 1 to day 8, memory impairment was detected 20 min and 24 h after each injection.
Separation of humoral glycolipids. After the 8 daily injections of LPS (2.5 mg/kg) or PS, we collected sera from the mice. Glycolipids were separated from each serum sample as described previously (6) . In brief, 4 mL sera was added to 10 mL methanol and 5 mL chloroform. The solution was agitated for 2 min 
Effects of repeated injections of low-dose LPS
We investigated the effects of repeated treatment with low-dose LPS. As shown in Table 2 , 4 of 9 mice showed memory impairment 20 min after the 6th daily injection of 2.5 mg/kg LPS, 7 showed impairment 20 min after the 7th daily injection, and all 9 of them showed impairment 20 min after the 8th daily injection. However, 24 h after each injection, none of the 9 mice showed impairment. All 9 mice treated with PS did not show impairment 20 min or 24 h after each treatment.
Subsidiary humoral glycolipid
We suspected that mice repeatedly injected with lowdose LPS were affected by a metabolite of LPS. A single injection of 300 μL humoral glycolipid, eluted with 50, 100, 150, 200, 250, or 300 mM NaCl, from the sera of memory-impaired mice did not induce memory impairment in the prepared 5 mice. However, an additional 2.5 mg/kg LPS administered by single injection caused memory impairment only in mice previously treated with the 250 mM NaCleluted glycolipid fraction (data not shown). Table 3 shows the dose dependency of the glycolipid eluted with 250 mM NaCl. Two of 5 mice treated with 300 μg/kg of the glycolipid showed impairment 20 min after a single injection of 2.5 mg/kg LPS, and all 5 of them treated with 500 μg/kg of the glycolipid showed impairment after a single injection Tokyo, Japan). After 30 min of blocking with 5% bovine serum albumin (Sigma Aldrich), the well was washed three times with WS. One hundred microliters of 8 different biotinized lectins recognizing the sugar chain structure (AAL: Fuc α1-3 GalNAc, ConA: polymannoses, DBA: GalNAc β1-3 GalNAc, DSA: Gal β1-4 GlcNAc, MAM: Sial α2-3 Gal, PNA: Gal β1-3 GalNAc, SBA: GalNAc β1-3 Gal, and SSA: Sial α2-6 Gal), which were diluted to 2 μg/mL with PS, were poured into each well. One hour after incubation at RT, each well was washed three times with WS. One hundred microliters of peroxidase-conjugated avidin (Seikagaku Co.) diluted to 0.1 μg/mL with PS was poured into each well. After 15 min at RT, each well was treated with the coloring kit (Sumitomo Bakelite Co.), and light absorbance was measured at dual wavelengths of 455 and 650 nm.
Statistical analysis. The Kruskal-Wallis rank test was used to find significant differences among the clusters. After significant differences were found (P < 0.01), the Mann-Whitney U-test was used.
RESULTS

Effects of LPS single injection
Mice showed memory impairment 20 min after the 25 mg/kg LPS injection but not after a single injection of 15 or 20 mg/kg LPS (Table 1) . (4) LPS contained polymannoses and Gal β1-3 GalNAc, and the humoral glycolipid contained Gal β1-3 GalNAc but not polymannoses (Table 4 ). In summary, the present findings suggest that LPS directly and temporarily depresses hippocampal neuron activity, and that the humoral glycolipid detected after repeated LPS injection is the metabolite associated with the memory-impairing effect of LPS. LPS have unique and abundant glycolipids found in the outer membranes of gram-negative bacteria and have three structural domains. The hydrophobic lipid A forms the outer leaflet of the outer membrane and is responsible for the endotoxic properties of LPS. A short core oligosaccharide, such as the sugar chains detected in this study, extends from lipid A. In many bacteria, the core is capped with a repeating unit glycan polymer known as the O antigen. Polymannose is the O antigen of the LPS we studied. Lipid A is structurally conserved among gram-negative bacteria, whereas limited variability of the core oligosaccharide is often observed within species (8) .
Exclusion of terminal sugar mannose might be the initial step of LPS metabolism in blood. This would explain why only Gal β1-3 GalNAc-lipid reactivity was detected in the sera of mice repeatedly treated with LPS (Fig. 2) .
As neurons have a mannose-binding receptor (1), polymannoses of LPS may directly decrease hippocampal neuron activity. In fact, mannose deposit has of 2.5 mg/kg LPS. These effects disappeared 24 h after the LPS injection.
Sugar chain constitution of humoral glycolipid
LPS are composed of a sugar chain portion and a lipid portion. LPS of E. coli 044 is polymannosesGal β1-3 GalNAc-lipid. Gal β1-3 GalNAc reactivity was detected in the 250 mM NaCl-eluted glycolipid fraction from the sera of memory-impaired mice, but polymannose reactivity was not. Both Gal β1-3 GalNAc and polymannose reactivities were not detected in the glycolipid fraction eluted from the sera of control mice with 250 mM NaCl. These findings are shown in Table 4 . No other sugar chain structures (Fuc α1-3 GalNAc, GalNAc α1-3 GalNAc, Gal β1-4 GlaNAc, Sial α2-3 Gal, GalNAc α1-3 Gal, and Sial α2-6 Gal) were detected in all samples.
DISCUSSION
Our experiments clearly demonstrate the following points: (1) LPS single injection induced memory impairment in mouse 20 min after injection but not 24 h later (Table 1) ; (2) the LPS dose required to impair mouse memory was smaller in the total of repeated injections than the dose of single injection (Table 2) ; (3) the humoral glycolipid detected in memory-impaired mouse serum did not have a memory-impairing effect by itself but induced the effect after injection of 2.5 mg/kg LPS (Table 3) ; and Twenty minutes after the LPS injection mice exhibit statistical differences (k = 3, n 1 = n 2 = n 3 = 5, n = 15, H = 12.5, P < 0.009 Kruskal-Wallis rank test). *P < 0.01 compared with mice pretreated with 10 mg/kg of the glycolipid (Mann-Whitney U-test). been detected in the dentate gyrus of the hippocampus among patients with brain dysfunctions (7) . It has been reported that mannose and polymannose penetrate the blood-brain barrier; on the other hand, it has been reported that GM1 ganglioside induces the cocaine transporter in the blood-brain barrier (10) . These may suggest a mechanism for the subsidiary effect of the humoral Gal β1-3 GalNAc-lipid. Namely, it appears that the humoral Gal β1-3 GalNAclipid might induce a polymannose transporter in the blood-brain barrier, although such a transporter has not been identified. The present findings suggest a possible mechanism by which delirium is induced by chronic infection, such as that found among the elderly. Among aged patients with dementia, memory may be improved with the removal of humoral Gal β1-3 GalNAclipid.
